Another study showed that bufalin, a cardiotonic steroid, reduced the expressions of antiapoptotic protein Bcl-2 and surviving and increased the proapoptotic protein Bax/Bcl-2 rate in several different cancer types [29]. This evidence concerns the gene BCL2 and cancer.